Literature DB >> 21136306

An emerging problem in clinical practice: how to treat chronic headache patients.

Luigi Alberto Pini1.   

Abstract

Entities:  

Mesh:

Year:  2010        PMID: 21136306     DOI: 10.1007/s11739-010-0484-4

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  10 in total

Review 1.  Epidemiology of headache in Europe.

Authors:  L J Stovner; J-A Zwart; K Hagen; G M Terwindt; J Pascual
Journal:  Eur J Neurol       Date:  2006-04       Impact factor: 6.089

Review 2.  Pharmacogenomics in migraine: catching biomarkers for a predictable disease control [corrected].

Authors:  Maurizio Simmaco; Marina Borro; Serena Missori; Paolo Martelletti
Journal:  Expert Rev Neurother       Date:  2009-09       Impact factor: 4.618

Review 3.  New therapeutic developments in chronic migraine.

Authors:  Brigitte V Lovell; Michael J Marmura
Journal:  Curr Opin Neurol       Date:  2010-06       Impact factor: 5.710

4.  Medication overuse headache: withdrawal and prophylactic therapeutic regimen.

Authors:  Marco Trucco; Piero Meineri; Luigi Ruiz; Maurizio Gionco
Journal:  Headache       Date:  2010-03-05       Impact factor: 5.887

5.  Glutamate and nitric oxide pathway in chronic daily headache: evidence from cerebrospinal fluid.

Authors:  V Gallai; A Alberti; B Gallai; F Coppola; A Floridi; P Sarchielli
Journal:  Cephalalgia       Date:  2003-04       Impact factor: 6.292

Review 6.  Rehabilitating chronic migraine complicated by medication overuse headaches: how can we prevent migraine relapse?

Authors:  Ivano Farinelli; Ilaria Dionisi; Paolo Martelletti
Journal:  Intern Emerg Med       Date:  2010-05-22       Impact factor: 3.397

7.  Upregulation of spinal glutamate receptors in chronic pain.

Authors:  J A Harris; M Corsi; M Quartaroli; R Arban; M Bentivoglio
Journal:  Neuroscience       Date:  1996-09       Impact factor: 3.590

8.  A double-blind comparison of onabotulinumtoxina (BOTOX) and topiramate (TOPAMAX) for the prophylactic treatment of chronic migraine: a pilot study.

Authors:  Ninan T Mathew; Sayyed Farhan A Jaffri
Journal:  Headache       Date:  2009 Nov-Dec       Impact factor: 5.887

Review 9.  A narrative review on the management of medication overuse headache: the steep road from experience to evidence.

Authors:  Paolo Rossi; Rigmor Jensen; Giuseppe Nappi; Marta Allena
Journal:  J Headache Pain       Date:  2009-10-03       Impact factor: 7.277

10.  Intracellular messengers contributing to persistent nociception and hyperalgesia induced by L-glutamate and substance P in the rat formalin pain model.

Authors:  T J Coderre; K Yashpal
Journal:  Eur J Neurosci       Date:  1994-08-01       Impact factor: 3.386

  10 in total
  1 in total

1.  Increased efficacy of regularly repeated cycles with OnabotulinumtoxinA in MOH patients beyond the first year of treatment.

Authors:  Simona Guerzoni; Lanfranco Pellesi; Carlo Baraldi; Luigi Alberto Pini
Journal:  J Headache Pain       Date:  2016-05-04       Impact factor: 7.277

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.